Key statistics
On Tuesday, United Therapeutics Corp (UTH:DUS) closed at 378.70, -3.17% below its 52-week high of 391.10, set on Nov 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 373.70 |
---|---|
High | 380.80 |
Low | 373.70 |
Bid | 376.70 |
Offer | 377.80 |
Previous close | 374.60 |
Average volume | 28.11 |
---|---|
Shares outstanding | 44.64m |
Free float | 43.81m |
P/E (TTM) | 17.60 |
Market cap | 17.88bn USD |
EPS (TTM) | 22.75 USD |
Data delayed at least 15 minutes, as of Nov 12 2024 18:30 GMT.
More ▼
Press releases
- United Therapeutics Corporation to Present at the UBS Global Healthcare Conference
- United Therapeutics Corporation Reports Third Quarter 2024 Financial Results
- United Therapeutics Corporation Announces the 500th Lung Transplant Utilizing its Centralized Ex Vivo Lung Perfusion Service
- United Therapeutics Corporation to Report Third Quarter 2024 Financial Results Before the Market Opens on Wednesday, October 30, 2024
- United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2024 Annual Meeting
- United Therapeutics Publishes its 2024 Corporate Responsibility and Public Benefit Report Highlighting its Progress Toward a Future Where No Patient Gets Left Behind—Ever
- United Therapeutics Corporation to Present at Upcoming Investor Conferences
More ▼